Formulations, methods, kits, and dosage forms
AssigneeMedRegen, LLC
InventorsZhaoli Sun, John Sun, Christy Eatmon, Rachel Labell, Zhimin Liu, Richard Brewer, Isaac Agyemang, Mitchell Williams
Life of this patent
Estimating the term…
Abstract
Embodiments of the disclosure relate generally to formulations, methods, kits, and dosage forms for improved stability comprising at least two active ingredients, AMD3100, or similar stem cell mobilizer, and Tacrolimus, or FK506 derivative or analog, and one or more excipients. The formulations may be administered as a single dose subcutaneous injection. The formulations may be useful in treating various diseases, disorders or injuries.
Claims17
A method for treating one or more disorders, diseases or injuries comprising administering to a subject or patient in need thereof a pharmaceutical formulation comprising:
- AMD 3100 or similar stem cell mobilizer;
- Tacrolimus of a FL506 derivative or analog;
- and
- one or more excipients.
A method of manufacturing a pharmaceutical formulation comprising:
- AMD 3100 or similar stem cell mobilizer;
- Tacrolimus of a FL506 derivative or analog;
- and
- one or more excipients.
Dependencies are inferred from the claim text.